|
Volumn 10, Issue 2, 2009, Pages 167-169
|
Acute bioprosthetic thrombosis immediately after aortic valve replacement
|
Author keywords
Aortic valve replacement complication; Bioprosthetic thrombosis; Carpentier Magna
|
Indexed keywords
ADRENALIN;
DOBUTAMINE;
HEPARIN;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
INOTROPIC AGENT;
PROTAMINE SULFATE;
ANTICOAGULANT AGENT;
CARDIOTONIC AGENT;
AGED;
ANGIOCARDIOGRAPHY;
AORTA BALLOON;
AORTA SINUS;
AORTA STENOSIS;
AORTA VALVE REGURGITATION;
AORTA VALVE REPLACEMENT;
ARTICLE;
ARTIFICIAL EMBOLISM;
BIOPROSTHESIS;
CARDIOPLEGIA;
CARPENTIER EDWARDS BIOPROSTHESIS;
CASE REPORT;
CORONARY ARTERY OBSTRUCTION;
DEEP VEIN THROMBOSIS;
DEVICE REMOVAL;
DISEASE EXACERBATION;
DYSPNEA;
ECG ABNORMALITY;
ECHOCARDIOGRAPHY;
ELECTROCARDIOGRAPHY;
ENDOTHELIUM LESION;
ERYTHROCYTE COUNT;
EXTRACORPOREAL CIRCULATION;
FEMALE;
FEMORAL ARTERY;
GENERAL CONDITION DETERIORATION;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART LEFT VENTRICLE HYPERTROPHY;
HEART VENTRICLE CONTRACTION;
HEART VENTRICLE EXTRASYSTOLE;
HEART VENTRICLE FIBRILLATION;
HEMOSTASIS;
HOSPITAL ADMISSION;
HUMAN;
HYPERCOAGULABILITY;
HYPERTENSION;
INTERNATIONAL NORMALIZED RATIO;
MITRAL VALVE REGURGITATION;
PEROPERATIVE COMPLICATION;
PROSTHESIS FAILURE;
PROSTHETIC VALVE THROMBOSIS;
SINUS RHYTHM;
ST SEGMENT;
THROMBOCYTE COUNT;
VERTIGO;
AORTA VALVE STENOSIS;
CARDIOVERSION;
HEART VALVE PROSTHESIS;
HEART VALVE REPLACEMENT;
INSTRUMENTATION;
PATHOLOGY;
PROSTHESIS;
REOPERATION;
RISK FACTOR;
THROMBOSIS;
TREATMENT OUTCOME;
AGED;
ANTICOAGULANTS;
AORTIC VALVE STENOSIS;
BIOPROSTHESIS;
CARDIOTONIC AGENTS;
DEVICE REMOVAL;
ELECTRIC COUNTERSHOCK;
FEMALE;
HEART VALVE PROSTHESIS;
HEART VALVE PROSTHESIS IMPLANTATION;
HUMANS;
INTRA-AORTIC BALLOON PUMPING;
PROSTHESIS DESIGN;
PROSTHESIS FAILURE;
REOPERATION;
RISK FACTORS;
THROMBOSIS;
TREATMENT OUTCOME;
VENTRICULAR FIBRILLATION;
|
EID: 65549099743
PISSN: 15582027
EISSN: None
Source Type: Journal
DOI: 10.2459/JCM.0b013e32831a9a98 Document Type: Article |
Times cited : (5)
|
References (6)
|